Friedrich J. Wiebel
Friedrich J. Wiebel publishes mostly in Cancer Research, Pharmacology and Molecular Biology, on topics such as Carcinogens and Genotoxicity Assessment, Pharmacogenetics and Drug Metabolism and Toxic Organic Pollutants Impact.
- World rank
- #1,169,491 of 7,710,434 ranked researchers
- Rank in Germany
- #57,544 of 364,343
- Works
- 112
- Citations
- 3.4k
- Citations per work
- 30.0
What does Friedrich J. Wiebel research?
Friedrich J. Wiebel's work is mostly in Biochemistry, Genetics and Molecular Biology (37%), Pharmacology, Toxicology and Pharmaceutics (16%), Environmental Science (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences5952.8%
- Everything else3430.1%
- Physical Sciences1412.5%
- Environmental Science1412.5%
- Health Sciences54.6%
- Medicine54.6%
- 1Cancer Research16% of their works
- 2Pharmacology16% of their works
- 3Molecular Biology15% of their works
- 4Health, Toxicology and Mutagenesis12% of their works
- 5Biochemistry5% of their works
- 6Oncology5% of their works
Research topics
- Carcinogens and Genotoxicity Assessment
- Pharmacogenetics and Drug Metabolism
- Toxic Organic Pollutants Impact
- Effects and risks of endocrine disrupting chemicals
- Drug Transport and Resistance Mechanisms
- Eicosanoids and Hypertension Pharmacology
- Glutathione Transferases and Polymorphisms
- Metabolism and Genetic Disorders
Which keywords describe Friedrich J. Wiebel's research?
The keywords of their largest research topics: Cytochrome P450, Drug Metabolism, Comet Assay, Genotoxicity Testing, Genetic Variation, Pharmacogenetics, Environmental Exposure and Brominated Flame Retardants.
- Newborn Screening
- Superoxide Dismutase
- Epoxyeicosatrienoic Acids
- Multidrug Resistance
- Endocrine-Disrupting Chemicals
- Metabolic Disorders
- Brominated Flame Retardants
- Pharmacogenetics
- Genotoxicity Testing
- Drug Metabolism
- Cytochrome P450
- Comet Assay
- Genetic Variation
- Environmental Exposure
- Polycyclic Aromatic Hydrocarbons
- Bisphenol A
- ATP-dependent Transporters
- Arachidonic Acid
- Glutathione Transferases
- Biochemical Genetics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Cytochrome P450492 topics
- Drug Metabolism492 topics
- Comet Assay471 topic
- Genotoxicity Testing471 topic
- Genetic Variation411 topic
- Pharmacogenetics411 topic
- Environmental Exposure332 topics
- Brominated Flame Retardants211 topic
- Polycyclic Aromatic Hydrocarbons211 topic
- Metabolic Disorders182 topics
- Bisphenol A121 topic
- Endocrine-Disrupting Chemicals121 topic
- ATP-dependent Transporters101 topic
- Multidrug Resistance101 topic
- Arachidonic Acid81 topic
- Epoxyeicosatrienoic Acids81 topic
- Glutathione Transferases81 topic
- Superoxide Dismutase81 topic
- Biochemical Genetics61 topic
- Newborn Screening61 topic
Where does Friedrich J. Wiebel work?
Friedrich J. Wiebel's main affiliation in the publication record is Munich Security Conference, Germany.
How many publications and citations does Friedrich J. Wiebel have?
OpenAlex counts 112 works and 3,361 citations for Friedrich J. Wiebel, an h-index of 33, ranking #1,169,491 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Friedrich J. Wiebel. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.